ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Dan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9758-3614; OpenAlex author ID A5100411863. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2023.11.028 ↗
Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. Co-author DOI 10.1016/j.ejps.2021.106000 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guimin Xia · 2 shared papers, 2021–2024 · strength 0.34
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗
Xiaowei Wang · 2 shared papers, 2021–2024 · strength 0.34
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗
Mingliang Liu · 1 shared paper, 2024 · strength 0.20
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
Hongwei Lü · 1 shared paper, 2024 · strength 0.20
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
Jie Ma · 1 shared paper, 2021 · strength 0.13
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗
Qingfang Miao · 1 shared paper, 2021 · strength 0.13
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.